Literature DB >> 17565263

[A case of liver failure associated with liver damage due to mFOLFOX 6 after resection for multiple liver metastases from colorectal cancer].

Tetsuo Ishizaki1, Tomomi Abe, Yasuhisa Koyanagi, Kenji Katsumata, Tatehiko Wada, Akihiko Tsuchida, Tatsuya Aoki.   

Abstract

A case of colorectal cancer in a 60-year-old man became resectable after downstaging was achieved with mFOLFOX 6 for multiple liver metastases from colorectal cancer. The patient received 8 cycles of mFOLFOX 6 on the basis of a diagnosis of multiple liver metastases in the right and left lobes and a single metastasis in the right lung. After chemotherapy, the liver metastases showed partial response, and the lung metastasis stable disease. Because the lung metastasis was controlled and radical cure of the liver metastases was thought possible by resection, we performed right lobectomy of the liver. Postoperative progress was good, and we then planned a staged partial resection of the lung. However,on postoperative day 28, the patient was hospitalized again with liver dysfunction, which evolved into liver failure, in spite of conservative treatment. The patient died on postoperative day 95. The needle biopsy specimens of the liver taken on readmission showed bile duct occlusion, portal hypertension, and perisinusoidal fibrosis, and histopathology of the surgical non-tumoral liver specimen showed the same findings. We think that liver failure was triggered by resection of the liver which had been damaged by mFOLFOX 6. Recently, liver damage due to oxaliplatin was reported, and evaluation of liver injury is considered important before liver resection for colorectal liver metastases with neoadjuvant FOLFOX.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17565263

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  3 in total

1.  Accuracy of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of sinusoidal obstruction syndrome in patients with chemotherapy-treated colorectal liver metastases.

Authors:  Na-Young Shin; Myeong-Jin Kim; Joon Seok Lim; Mi-Suk Park; Yong-Eun Chung; Jin-Young Choi; Ki Whang Kim; Young-Nyun Park
Journal:  Eur Radiol       Date:  2011-11-23       Impact factor: 5.315

2.  Comparison Between Liver Stiffness Measurement by Fibroscan and Splenic Volume Index as NonInvasive Tools for the Early Detection of Oxaliplatin-induced Hepatotoxicity.

Authors:  Youssef Bouferraa; Yolla Haibe; Elio Jabra; Maya Charafeddine; Malek Kreidieh; Randa Raad; Sally Temraz; Deborah Mukherji; Firas Ershaid; Nadim Muallem; Walid Faraj; Mohamad Khalife; Rania A Eid; Ali Shamseddine
Journal:  J Clin Exp Hepatol       Date:  2021-06-15

3.  Long-term follow-up of oxaliplatin-induced liver damage in patients with colorectal cancer.

Authors:  Dong Ik Cha; Kyoung Doo Song; Sang Yun Ha; Jung Yong Hong; Jeong Ah Hwang; Seong Eun Ko
Journal:  Br J Radiol       Date:  2021-06-16       Impact factor: 3.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.